BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 994-999

  Shih, Helen A ^a   Couch, Fergus J ^a   Nathanson, Katherine L ^a   Anne Blackwood, M ^a   Rebbeck, Timothy R ^a   Armstrong, Katrina A ^a   Calzone, Kathleen ^a   Stopfer, Jill ^a   Seal, Sheila ^a   Stratton, Michael R ^a   Weber, Barbara L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; JEW; MAJOR CLINICAL STUDY; MALE; MALE BREAST; ONSET AGE; OVARY CANCER; PENETRANCE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; JEWS; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; PREVALENCE; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 0037083566     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.994     Document Type: Article

References (29)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
4. Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium
5. Risks of cancer in BRCA1-mutation carriers: Breast Cancer Linkage Consortium
6. Frequency and carrier associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
7. Breast Cancer Linkage Consortium: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
8. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
9. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
10. Contribution of BRCA1 mutations to ovarian cancer
11. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
12. Linkage of early-onset familial breast cancer to chromosome 17q21
13. Identifying women with inherited risk forovarian cancer: Who and why?
14. Familial breast-ovarian cancer locus on chromosome 17q12-q23
15. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
16. BRCA1 and BRCA2 mutations in patients with multiple primary cancers
17. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
18. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13
19. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes
20. Genetic analysis of breast cancer in the cancer and steroid hormone study
21. Factors associated with decisions about clinical BRCA1/2 testing
22. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: Two recurrent mutations seem to account for all BRCA1/BRCA32 linked breast cancer in Iceland
23. BRCA2 mutations in hereditary breast and ovarian cancer in France
24. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
25. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
26. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
27. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
28. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
29. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing